drugset / Trial / NCT03157791

Simethicone and Bowel Preparation in Colonoscopy

NCT03157791

Phase 4 Completed 471 enrolled University of Manitoba
RandomizedParallel-groupDouble-blindDiagnostic

Summary

This Clinical Trial is being conducted to study the effect of oral simethicone on the presence of bubbles during colonoscopy. The purpose of this study is to find out what effects (good and bad) the addition of oral simethicone to bowel preparation has on the ability to visualize the colon mucosa (bowel) during colonoscopy.

Timeline

Start
2017-07-05
Primary completion
2017-11-26
Completion
2017-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Simethicone Other / unclassified 180 mg Oral

Indications

No indication recorded.